Sector valuations Vertex Pharmaceuticals Incorporated

Stocks

Real-time Estimate Cboe BZX 20:05:05 29/09/2026 BST			5-day change	1st Jan Change
527.31 ^USD	-0.07%		+2.50%	+16.43%

09-28	UBS Raises Vertex Pharmaceuticals Price Target to $615 From $585, Maintains Buy Rating	MT
09-23	TD Cowen Adjusts PT on Vertex Pharmaceuticals to $550 From $525, Maintains Buy Rating	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	Price to Book (Y)	PEG (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Dividend Yield (Y)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	54.23x	8.56x	-1.49x	9.68x	33.18x	26.7x	-.--%	134B
ELI LILLY AND COMPANY	33.68x	21.4x	0.63x	12.2x	24.79x	26.23x	0.59%	1,056B
JOHNSON & JOHNSON	30.25x	-	-1.64x	6.73x	18.83x	21.16x	1.97%	655B
ABBVIE INC.	33.7x	-484.91x	0.14x	7.87x	16.27x	16.96x	2.61%	471B
ROCHE HOLDING AG	19.34x	7.07x	1.33x	4.71x	11.68x	12.95x	2.82%	342B
NOVARTIS AG	20.6x	5.86x	-11.89x	5.35x	13.29x	14.17x	2.98%	277B
ASTRAZENECA PLC	21.11x	4.76x	1.06x	4.38x	12.46x	13.11x	2.02%	257B
AMGEN INC.	26.41x	19.98x	2.34x	6.87x	12.24x	15.77x	2.41%	226B
GILEAD SCIENCES, INC.	-46.04x	11.33x	0.31x	6.69x	26.14x	63.43x	2.16%	189B
NOVO NORDISK A/S	11.29x	4.76x	-3.76x	4.12x	8.55x	10.02x	4.45%	170B
PFIZER INC.	18.11x	1.87x	1.09x	3.39x	8.69x	9.88x	5.99%	164B
BRISTOL-MYERS SQUIBB COMPANY	11.38x	5.36x	0.18x	3.19x	8.31x	8.95x	3.96%	130B
GSK PLC	14.43x	4.6x	-1.66x	2.82x	8.35x	9.29x	3.74%	98.8B
SANOFI	11.47x	1.17x	-6.07x	2.05x	6.64x	7.34x	5.91%	98.08B
CHUGAI PHARMACEUTICAL CO., LTD.	20.75x	4.67x	1.28x	6.91x	13.13x	13.82x	2.12%	66.5B
TAKEDA PHARMACEUTICAL COMPANY LIMITED	46.95x	1.27x	13.32x	2.84x	10.42x	28.45x	3.45%	60.16B
BAYER AG	23.04x	1.77x	-0.14x	1.74x	8.23x	14.11x	0.32%	56.74B
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	31.94x	4.31x	1.77x	7.43x	25.18x	28.16x	0.55%	43.61B
HALEON PLC	17.49x	1.77x	3.4x	3.24x	12.07x	13.44x	2.38%	39.73B
Average	21.06x	-20.80x	0.01x	5.38x	14.65x	18.63x	2.65%	238.65B
Weighted average by Cap.	24.27x	-48.82x	-0.58x	7.20x	17.24x	20.22x	2.22%